The realm of cell and gene therapies (CGTs) has long been heralded as a revolutionary frontier in medicine, promising transformative outcomes for patients with previously untreatable conditions, yet it faces significant hurdles in securing consistent funding. As the industry matures, it confronts a
In an era where artificial intelligence is reshaping countless industries, a chilling possibility has emerged at the intersection of AI and synthetic biology, raising urgent questions about global safety. Imagine a scenario where malicious actors harness sophisticated algorithms to reengineer
What if a technology could transform the way doctors analyze intricate medical scans, cutting down hours of work into mere minutes with unerring precision, while making diagnostics more accessible worldwide? Picture a hospital overwhelmed with brain MRI scans, where clinicians struggle to keep up
In a world where obesity rates have more than doubled since 1990, the accumulation of excess body fat, known as adiposity, has emerged as a critical public health challenge with profound implications for mortality and chronic disease risk. This staggering rise positions adiposity as a leading
Imagine a world where life-saving biologics are produced faster, more efficiently, and at a scale never seen before, directly impacting millions of lives across the globe with groundbreaking advancements. This vision is becoming reality in Europe, where the biotech sector is witnessing a
I'm thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with a wealth of experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the exciting collaboration between two leaders in laboratory
Imagine a scenario where a child undergoes surgery, and the anesthesiologist receives a critical alert about a potential oxygen drop 60 seconds before it becomes life-threatening, thanks to the power of artificial intelligence (AI) in pediatric anesthesia. This is no longer a distant dream but a
In a world where medical breakthroughs are happening at an unprecedented pace, the challenge of ensuring timely access to cutting-edge technologies while maintaining rigorous safety standards has never been more critical. A groundbreaking collaboration between the UK’s Medicines and Healthcare
As we delve into the complex world of cancer biology, I’m thrilled to speak with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development. Ivan’s deep knowledge of technology and innovation in the industry offers unique insights into groundbreaking studies,
Imagine a region where the demand for life-changing biopharmaceuticals is skyrocketing, yet the race to deliver these treatments faster and more efficiently is becoming increasingly competitive. Asia, with its dynamic healthcare landscape, stands at the forefront of this challenge, particularly in
